Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Barrett

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Wiener Medizinische Wochenschrift (1946)|April 30, 1986
[Molecular biology of human T-lymphotropic retroviruses (HTLV)]F Dorner, P N Barrett, B L Schmidt, et al.
The Journal of General Virology|July 1, 1985
Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell lineP N Barrett, K Koschel, M Carter, et al.
Developments in Biological Standardization|January 1, 1993
Minimum safety requirements for preclinical testingF Dorner, P N Barrett, H P Schwartz, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Natural IgM antibodies in baby rabbit serum bind high-mannose glycans on HIV type 1 glycoprotein 120/160 and activate classic complement pathwayM Gerencer, P N Barrett, O Kistner, et al.
Transfusion|February 1, 1997
Inactivation of hepatitis A virus in plasma products by vapor heatingP N Barrett, H Meyer, I Wachtel, et al.
Journal of Medical Virology|May 1, 1996
Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assayP N Barrett, H Meyer, I Wachtel, et al.
Wiener Klinische Wochenschrift|June 23, 1989
[Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV]P N Barrett, F Dorner, G Stingl, et al.
Vaccine|July 31, 1998
Development of a mammalian cell (Vero) derived candidate influenza virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Wiener Klinische Wochenschrift|May 5, 1999
A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale productionO Kistner, P N Barrett, W Mundt, et al.
Developments in Biological Standardization|September 24, 1999
Development of a Vero cell-derived influenza whole virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Wiener Medizinische Wochenschrift (1946)|April 30, 1986
[Molecular biology of human T-lymphotropic retroviruses (HTLV)]F Dorner, P N Barrett, B L Schmidt, et al.
The Journal of General Virology|July 1, 1985
Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell lineP N Barrett, K Koschel, M Carter, et al.
Developments in Biological Standardization|January 1, 1993
Minimum safety requirements for preclinical testingF Dorner, P N Barrett, H P Schwartz, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Natural IgM antibodies in baby rabbit serum bind high-mannose glycans on HIV type 1 glycoprotein 120/160 and activate classic complement pathwayM Gerencer, P N Barrett, O Kistner, et al.
Transfusion|February 1, 1997
Inactivation of hepatitis A virus in plasma products by vapor heatingP N Barrett, H Meyer, I Wachtel, et al.
Journal of Medical Virology|May 1, 1996
Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assayP N Barrett, H Meyer, I Wachtel, et al.
Wiener Klinische Wochenschrift|June 23, 1989
[Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV]P N Barrett, F Dorner, G Stingl, et al.
Vaccine|July 31, 1998
Development of a mammalian cell (Vero) derived candidate influenza virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Wiener Klinische Wochenschrift|May 5, 1999
A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale productionO Kistner, P N Barrett, W Mundt, et al.
Developments in Biological Standardization|September 24, 1999
Development of a Vero cell-derived influenza whole virus vaccineO Kistner, P N Barrett, W Mundt, et al.
Pageof 3